EQS Group-Media / 2019-10-08 / 19:05
*Press Release*
*Medacta Receives CE Marking for the Lateralized Glenosphere*
_CASTEL SAN PIETRO_, _8 October 2019_ - Medacta International has recently
obtained CE marking for the lateralized glenosphere. This new implant
further expands the Medacta offering for shoulder arthroplasty, which now
features a broader range of options for reverse shoulder replacement
surgery.
The Medacta Shoulder System is a modular solution that includes wide-ranging
sizes, adjustable offset and innovative configurations both in the anatomic
and reverse configuration. It is compatible with, and can be further
enhanced by, the CT-based MyShoulder 3D preoperative planning solution,
offering patient-specific humeral and glenoid guides.
The lateralized glenosphere features a more lateralized centre of rotation
compared to the standard glenosphere already included in the Medacta
Shoulder System offering. The potential benefits are an improved range of
motion, as well as a reduced risk of scapular notching.
This new CE mark clearance exemplifies Medacta's continuous commitment to
leverage expertise gained throughout orthopaedics for the development of
exceptional shoulder solutions.
For more information on Medacta Shoulder System and Medacta's shoulder
arthroplasty solutions, visit https://www.medacta.com/EN/global-shoulder
[1].
*Contact*
Medacta International SA
Gianluca Olgiati
Senior Director Global Marketing
Phone: +41 91 696 60 60
media@medacta.ch
*About Medacta*
Medacta is an international company specializing in the design and
production of innovative orthopaedic products and the development of
accompanying surgical techniques. Established in 1999 in Switzerland,
Medacta's products and surgical techniques are characterized by innovation.
Medacta is a pioneer in developing new offerings on the basis of minimally
invasive surgical techniques, in particular its Anterior Minimally Invasive
Surgery ("AMIS") technique for hip replacements. Medacta has leveraged its
orthopaedic expertise and comprehensive understanding of the human body to
develop the sophisticated "MySolutions" technology, which offers surgeons
highly personalized pre-operative planning and implant placement
methodologies by creating advanced personalized kinematic models and 3D
planning tools for use in hip, knee, shoulder and spine procedures.
Additional features:
Document: http://n.eqs.com/c/fncls.ssp?u=LRTMPBMUWY [2]
Document title: Medacta Receives CE Marking for the Lateralized Glenosphere
Issuer: Medacta Group SA
Key word(s): Advertisement/Communication
End of Corporate News
Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 696 6060
E-mail: info@medacta.ch, investor.relations@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 887253
End of News EQS Group Media
887253 2019-10-08
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=1321e0aebb484f68b82d52d43490bca2&application_id=887253&site_id=vwd&application_name=news
2: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=17cee4e22e4e873b46ea36f503fd7bd0&application_id=887253&site_id=vwd&application_name=news
(END) Dow Jones Newswires
October 08, 2019 13:05 ET (17:05 GMT)
© 2019 Dow Jones News